Definitive Healthcare Corp. (NASDAQ: DH) Stock Competitors & Peer Comparison

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas GEHCV's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, DH is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for DH.Check GEHCV's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, TEM has a market cap of 13.5B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while TEM trades at $77.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas TEM's P/E ratio is -154.38. In terms of profitability, DH's ROE is -0.79%, compared to TEM's ROE of -0.55%. Regarding short-term risk, DH is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for DH.Check TEM's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, BTSG has a market cap of 11.1B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while BTSG trades at $56.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas BTSG's P/E ratio is 38.47. In terms of profitability, DH's ROE is -0.79%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, DH is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for DH.Check BTSG's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, BTSGU has a market cap of 10.9B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while BTSGU trades at $187.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas BTSGU's P/E ratio is 126.58. In terms of profitability, DH's ROE is -0.79%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, DH is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for DH.Check BTSGU's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SGFY's P/E ratio is 70.91. In terms of profitability, DH's ROE is -0.79%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, DH is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for DH.Check SGFY's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, HQY has a market cap of 7.7B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while HQY trades at $91.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas HQY's P/E ratio is 21.44. In terms of profitability, DH's ROE is -0.79%, compared to HQY's ROE of +0.11%. Regarding short-term risk, DH is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for DH.Check HQY's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, HNGE has a market cap of 7.3B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while HNGE trades at $94.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas HNGE's P/E ratio is 50.36. In terms of profitability, DH's ROE is -0.79%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, DH is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for DH.Check HNGE's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas RCM's P/E ratio is -102.21. In terms of profitability, DH's ROE is -0.79%, compared to RCM's ROE of +0.00%. Regarding short-term risk, DH is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for DH.Check RCM's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while DOCS trades at $26.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas DOCS's P/E ratio is 17.32. In terms of profitability, DH's ROE is -0.79%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, DH is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for DH.Check DOCS's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, WAY has a market cap of 4.9B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while WAY trades at $25.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas WAY's P/E ratio is 16.97. In terms of profitability, DH's ROE is -0.79%, compared to WAY's ROE of +0.04%. Regarding short-term risk, DH is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for DH.Check WAY's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, HTFL has a market cap of 4.3B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while HTFL trades at $50.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas HTFL's P/E ratio is -24.96. In terms of profitability, DH's ROE is -0.79%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, DH is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for DH.Check HTFL's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas ONEM's P/E ratio is -7.77. In terms of profitability, DH's ROE is -0.79%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, DH is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for DH.Check ONEM's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, PRVA has a market cap of 2.5B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while PRVA trades at $19.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas PRVA's P/E ratio is 92.67. In terms of profitability, DH's ROE is -0.79%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, DH is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for DH.Check PRVA's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas NXGN's P/E ratio is -266.00. In terms of profitability, DH's ROE is -0.79%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, DH is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for DH.Check NXGN's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, OMCL has a market cap of 1.5B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while OMCL trades at $33.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas OMCL's P/E ratio is 17.37. In terms of profitability, DH's ROE is -0.79%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, DH is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for DH.Check OMCL's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CERT has a market cap of 1.4B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CERT trades at $8.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CERT's P/E ratio is 22.08. In terms of profitability, DH's ROE is -0.79%, compared to CERT's ROE of -0.07%. Regarding short-term risk, DH is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for DH.Check CERT's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas AGTI's P/E ratio is -71.79. In terms of profitability, DH's ROE is -0.79%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, DH is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for DH.Check AGTI's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, OMDA has a market cap of 1.3B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while OMDA trades at $21.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas OMDA's P/E ratio is 305.29. In terms of profitability, DH's ROE is -0.79%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, DH is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for DH.Check OMDA's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while GDRX trades at $3.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas GDRX's P/E ratio is 10.75. In terms of profitability, DH's ROE is -0.79%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, DH is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for DH.Check GDRX's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while TDOC trades at $6.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas TDOC's P/E ratio is -6.42. In terms of profitability, DH's ROE is -0.79%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, DH is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for DH.Check TDOC's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CCLDO's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, DH is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for DH.Check CCLDO's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, HSTM has a market cap of 847.5M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while HSTM trades at $29.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas HSTM's P/E ratio is 40.29. In terms of profitability, DH's ROE is -0.79%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, DH is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for DH.Check HSTM's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SOPH has a market cap of 677M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SOPH trades at $8.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SOPH's P/E ratio is -7.27. In terms of profitability, DH's ROE is -0.79%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, DH is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for DH.Check SOPH's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, DH is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for DH.Check MPLN-WT's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, PHR has a market cap of 624.3M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while PHR trades at $10.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas PHR's P/E ratio is 36.07. In terms of profitability, DH's ROE is -0.79%, compared to PHR's ROE of +0.03%. Regarding short-term risk, DH is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for DH.Check PHR's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas ACCD's P/E ratio is -3.08. In terms of profitability, DH's ROE is -0.79%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, DH is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for DH.Check ACCD's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SHCR's P/E ratio is -3.76. In terms of profitability, DH's ROE is -0.79%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, DH is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for DH.Check SHCR's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CTEV has a market cap of 502.1M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CTEV trades at $29.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CTEV's P/E ratio is -1.73. In terms of profitability, DH's ROE is -0.79%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, DH is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for DH.Check CTEV's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, NRC has a market cap of 492.7M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while NRC trades at $21.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas NRC's P/E ratio is 26.66. In terms of profitability, DH's ROE is -0.79%, compared to NRC's ROE of +0.48%. Regarding short-term risk, DH is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for DH.Check NRC's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, EVH has a market cap of 426.3M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while EVH trades at $3.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas EVH's P/E ratio is 29.15. In terms of profitability, DH's ROE is -0.79%, compared to EVH's ROE of -0.99%. Regarding short-term risk, DH is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for DH.Check EVH's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CARL has a market cap of 419.2M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CARL trades at $15.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CARL's P/E ratio is -10.78. In terms of profitability, DH's ROE is -0.79%, compared to CARL's ROE of -0.38%. Regarding short-term risk, DH is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for DH.Check CARL's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SLGC's P/E ratio is -3.04. In terms of profitability, DH's ROE is -0.79%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, DH is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for DH.Check SLGC's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, DH's ROE is -0.79%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, DH is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for DH.Check SLGCW's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas TBRG's P/E ratio is 9.37. In terms of profitability, DH's ROE is -0.79%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, DH is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for DH.Check TBRG's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas MPLN's P/E ratio is -0.23. In terms of profitability, DH's ROE is -0.79%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, DH is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for DH.Check MPLN's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SY has a market cap of 367.4M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SY trades at $2.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SY's P/E ratio is -8.48. In terms of profitability, DH's ROE is -0.79%, compared to SY's ROE of -0.16%. Regarding short-term risk, DH is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for DH.Check SY's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas TRHC's P/E ratio is -4.27. In terms of profitability, DH's ROE is -0.79%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, DH is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for DH.Check TRHC's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SMFR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SMFR's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, DH is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for DH.Check SMFR's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, AMWL has a market cap of 224.2M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while AMWL trades at $13.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas AMWL's P/E ratio is -2.98. In terms of profitability, DH's ROE is -0.79%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, DH is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for DH.Check AMWL's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SPOK has a market cap of 219.9M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SPOK trades at $10.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SPOK's P/E ratio is 17.55. In terms of profitability, DH's ROE is -0.79%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, DH is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for DH.Check SPOK's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, LFMD has a market cap of 159.6M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while LFMD trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas LFMD's P/E ratio is -6.60. In terms of profitability, DH's ROE is -0.79%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, DH is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for DH.Check LFMD's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, LFMDP has a market cap of 159.2M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while LFMDP trades at $23.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas LFMDP's P/E ratio is -719.57. In terms of profitability, DH's ROE is -0.79%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, DH is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for DH.Check LFMDP's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, OPRX has a market cap of 143M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while OPRX trades at $7.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas OPRX's P/E ratio is 6.99. In terms of profitability, DH's ROE is -0.79%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, DH is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for DH.Check OPRX's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, HCAT has a market cap of 139.7M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while HCAT trades at $1.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas HCAT's P/E ratio is 9.45. In terms of profitability, DH's ROE is -0.79%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, DH is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for DH.Check HCAT's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CPSI's P/E ratio is -183.80. In terms of profitability, DH's ROE is -0.79%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, DH is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for DH.Check CPSI's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas AUGX's P/E ratio is -4.99. In terms of profitability, DH's ROE is -0.79%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, DH is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for DH.Check AUGX's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CCLD has a market cap of 91.4M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CCLD trades at $2.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CCLD's P/E ratio is 8.27. In terms of profitability, DH's ROE is -0.79%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, DH is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for DH.Check CCLD's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while WORX trades at $5.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas WORX's P/E ratio is -6.40. In terms of profitability, DH's ROE is -0.79%, compared to WORX's ROE of -0.35%. Regarding short-term risk, DH is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for DH.Check WORX's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while FORA trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas FORA's P/E ratio is -24.11. In terms of profitability, DH's ROE is -0.79%, compared to FORA's ROE of -0.17%. Regarding short-term risk, DH is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for DH.Check FORA's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CCLDP's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, DH is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for DH.Check CCLDP's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, ONMD has a market cap of 37.7M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while ONMD trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas ONMD's P/E ratio is -4.13. In terms of profitability, DH's ROE is -0.79%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, DH is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for DH.Check ONMD's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SNCE's P/E ratio is -0.27. In terms of profitability, DH's ROE is -0.79%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, DH is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for DH.Check SNCE's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas AKLI's P/E ratio is -0.71. In terms of profitability, DH's ROE is -0.79%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, DH is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for DH.Check AKLI's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SHLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SHLT's P/E ratio is -3.87. In terms of profitability, DH's ROE is -0.79%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, DH is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for DH.Check SHLT's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, DH's ROE is -0.79%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, DH is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for DH.Check SHCRW's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, ONMDW has a market cap of 26.3M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while ONMDW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas ONMDW's P/E ratio is -0.19. In terms of profitability, DH's ROE is -0.79%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, DH is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for DH.Check ONMDW's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas STRM's P/E ratio is -2.40. In terms of profitability, DH's ROE is -0.79%, compared to STRM's ROE of -0.65%. Regarding short-term risk, DH is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for DH.Check STRM's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas RNLX's P/E ratio is -0.33. In terms of profitability, DH's ROE is -0.79%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, DH is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for DH.Check RNLX's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas LIFW's P/E ratio is -0.02. In terms of profitability, DH's ROE is -0.79%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, DH is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for DH.Check LIFW's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas BBLN's P/E ratio is -0.04. In terms of profitability, DH's ROE is -0.79%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, DH is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for DH.Check BBLN's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, BFRG has a market cap of 10.7M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while BFRG trades at $0.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas BFRG's P/E ratio is -1.25. In terms of profitability, DH's ROE is -0.79%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, DH is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for DH.Check BFRG's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas ETAO's P/E ratio is -0.01. In terms of profitability, DH's ROE is -0.79%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, DH is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for DH.Check ETAO's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, MGRX has a market cap of 7.3M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while MGRX trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas MGRX's P/E ratio is -0.32. In terms of profitability, DH's ROE is -0.79%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, DH is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for DH.Check MGRX's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, DH is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for DH.Check UPH-WT's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while UPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas UPH's P/E ratio is -0.07. In terms of profitability, DH's ROE is -0.79%, compared to UPH's ROE of -1.05%. Regarding short-term risk, DH is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for DH.Check UPH's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas PEAR's P/E ratio is -0.08. In terms of profitability, DH's ROE is -0.79%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, DH is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for DH.Check PEAR's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas PEARW's P/E ratio is -0.00. In terms of profitability, DH's ROE is -0.79%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, DH is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for DH.Check PEARW's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas OTRK's P/E ratio is -0.02. In terms of profitability, DH's ROE is -0.79%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, DH is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for DH.Check OTRK's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, BFRGW has a market cap of 1.9M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while BFRGW trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas BFRGW's P/E ratio is -0.31. In terms of profitability, DH's ROE is -0.79%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, DH is less volatile compared to BFRGW. This indicates lower risk in terms of short-term price fluctuations for DH.Check BFRGW's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CMAX's P/E ratio is -0.00. In terms of profitability, DH's ROE is -0.79%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, DH is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for DH.Check CMAX's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while ACON trades at $2.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas ACON's P/E ratio is -0.29. In terms of profitability, DH's ROE is -0.79%, compared to ACON's ROE of -0.59%. Regarding short-term risk, DH is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for DH.Check ACON's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, DH is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for DH.Check LIFWZ's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, HCTI has a market cap of 999K. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while HCTI trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas HCTI's P/E ratio is -0.11. In terms of profitability, DH's ROE is -0.79%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, DH is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for DH.Check HCTI's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, DH's ROE is -0.79%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, DH is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for DH.Check VSEEW's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, DH is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for DH.Check MSPRZ's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, VSEE has a market cap of 307.6K. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while VSEE trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas VSEE's P/E ratio is -0.04. In terms of profitability, DH's ROE is -0.79%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, DH is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for DH.Check VSEE's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas KERNW's P/E ratio is -0.00. In terms of profitability, DH's ROE is -0.79%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, DH is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for DH.Check KERNW's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas KERN's P/E ratio is -0.01. In terms of profitability, DH's ROE is -0.79%, compared to KERN's ROE of -0.20%. Regarding short-term risk, DH is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for DH.Check KERN's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas LIFWW's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, DH is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for DH.Check LIFWW's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CMAXW's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, DH is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for DH.Check CMAXW's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, ZCMD has a market cap of 35.8K. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while ZCMD trades at $1.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, DH's ROE is -0.79%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, DH is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for DH.Check ZCMD's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, ACONW has a market cap of 15.7K. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while ACONW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas ACONW's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, DH is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for DH.Check ACONW's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CSLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CSLT's P/E ratio is -37.27. In terms of profitability, DH's ROE is -0.79%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, DH is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for DH.Check CSLT's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CHNG's P/E ratio is -152.72. In terms of profitability, DH's ROE is -0.79%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, DH is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for DH.Check CHNG's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CERN has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CERN's P/E ratio is 55.84. In terms of profitability, DH's ROE is -0.79%, compared to CERN's ROE of +0.14%. Regarding short-term risk, DH is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for DH.Check CERN's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CNVY trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CNVY's P/E ratio is -71.50. In terms of profitability, DH's ROE is -0.79%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, DH is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for DH.Check CNVY's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, IMS has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while IMS trades at $31.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas IMS's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to IMS's ROE of +0.27%. Regarding short-term risk, DH is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for DH.Check IMS's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas NAVA's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, DH is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for DH.Check NAVA's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas MTBC's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, DH is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for DH.Check MTBC's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas MTBCO's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, DH is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for DH.Check MTBCO's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas CHNGU's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, DH is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for DH.Check CHNGU's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas AFFX's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, DH is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for DH.Check AFFX's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while MSPRV trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas MSPRV's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to MSPRV's ROE of N/A. Regarding short-term risk, DH is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for DH.Check MSPRV's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while KURIU trades at $9.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas KURIU's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, DH is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for DH.Check KURIU's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, NH has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas NH's P/E ratio is -0.12. In terms of profitability, DH's ROE is -0.79%, compared to NH's ROE of +0.35%. Regarding short-term risk, DH is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for DH.Check NH's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas MTBCP's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, DH is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for DH.Check MTBCP's competition here

Definitive Healthcare Corp. (NASDAQ: DH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DH stands at 93.9M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, DH is priced at $0.89 on the NASDAQ, while SMFRW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DH currently has a P/E ratio of 3.42, whereas SMFRW's P/E ratio is N/A. In terms of profitability, DH's ROE is -0.79%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, DH is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for DH.Check SMFRW's competition here